Correction to: Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients (Clinical Rheumatology, (2022), 41, 12, (3879-3885), 10.1007/s10067-022-06348-z)

Yael Pri-Paz Basson, Oshrat E. Tayer-Shifman, Rawand Naser, Shelly Tartakover Matalon, Oded Kimhi, Raz Gepstein, Tamar Halperin, Tomer Ziv-Baran, Amit Ziv, Roma Parikh, Shaye Kivity*, Yair Levy

*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

Fingerprint

Dive into the research topics of 'Correction to: Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients (Clinical Rheumatology, (2022), 41, 12, (3879-3885), 10.1007/s10067-022-06348-z)'. Together they form a unique fingerprint.

Medicine & Life Sciences